Health and Fitness Health and Fitness
Thu, August 30, 2012
Wed, August 29, 2012
Tue, August 28, 2012
Mon, August 27, 2012
Sun, August 26, 2012
Sat, August 25, 2012
Fri, August 24, 2012
Thu, August 23, 2012
Wed, August 22, 2012
[ Wed, Aug 22nd 2012 ] - Market Wire
Inergetics Shareholder Update
Tue, August 21, 2012
Mon, August 20, 2012
[ Mon, Aug 20th 2012 ] - Market Wire
Watson Launches Generic Xopenex
Sat, August 18, 2012
Fri, August 17, 2012
Thu, August 16, 2012
Wed, August 15, 2012
Tue, August 14, 2012
Mon, August 13, 2012
Fri, August 10, 2012
Thu, August 9, 2012

Clinical Trials Continue on NTRR’s New Male Enhancement Supplements


//health-fitness.news-articles.net/content/2012/ .. rsquo-59-s-new-male-enhancement-supplements.html
Published in Health and Fitness on Thursday, August 23rd 2012 at 3:03 GMT by Market Wire   Print publication without navigation


TAMPA, Fla.--([ ])--Neutra Corp. (OTCBB: NTRR) announced today that clinical trials are proceeding as planned on two new supplements that the company hopes will help it carve out a foothold in the booming global market for all-natural male enhancement products.

"We believe weare very close to perfecting an all-natural formula that both men and women will love. Side effects donat belong in the bedroom, and weare working hard to make sure we deliver a product thatas safe and effective."

NTRR initiated the first round of clinical testing on the supplements late last month. The trials are part of NTRRas strategy to produce a safer, non-prescription alternative to popular male enhancers such as Viagra, which can carry potentially serious side effects. Clinical trials will be crucial to the process of fine-tuning the new formulas.

aWeare pleased with what weave seen so far in these clinical trials, and we plan to push forward until we achieve the results we want,a said NTRR CEO Michael-Shane Henderson. aWe believe weare very close to perfecting an all-natural formula that both men and women will love. Side effects donat belong in the bedroom, and weare working hard to make sure we deliver a product thatas safe and effective.a

Neutra Corp. is developing innovative, all-natural products to compete in the fast-growing nutraceuticals industry alongside Herbalife Ltd. (NYSE:HLF),Vitamin Shoppe (NYSE:VSI), Nutraceutical International Corp. (NASDAQ:NUTR) andSchiff Nutrition International Inc. (NYSE:WNI).

For more information on NTRRas nutraceuticals initiative, please visit [ www.neutracorp.com/investors ].

Follow NTRR on Twitter at[ www.twitter.com/neutracorp ].

About Neutra Corp.

Neutra Corp.([ www.neutracorp.com ]) is a healthy lifestyle company that specializes in the development and marketing of nutritional supplements, nutrient boosters, herbal remedies and othernatural wellnesssolutions. The company is currently working to produce a full range of products to address every component of a healthy lifestyle, including muscle building, weight loss and general wellness through a daily nutrition regimen. For investing information and performance data, please visit[ www.neutracorp.com/investors ].

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.


Publication Contributing Sources